EU for Evibodies

By Kate McDonald
Monday, 09 February, 2009

Arana Therapeutics has been granted an EU patent for its Evibodies range of small antibodies.

Evibodies were part of the technology platform brought into the company by EvoGenix when it merged with Peptech in 2007.

Evibodies are small fragments of a family of proteins that act like antibodies but are about one-tenth smaller.

They were given a US patent in 2007.

Government funding will enable researchers to test a suite of next-generation therapies they have...

Entelli-02 is a five-phage cocktail designed specifically to target Enterobacter cloacae...

Newborns who are exclusively fed colostrum in the first 72 hours following birth are five times...

Content from other channels on our network

Enartis to acquire Parsec in a wine industry deal

Six on the shelf: Summer treats by the block load

FMCG Industry Solutions acquires Ozflow Australia

Shaking up kids' drinks using sustainable packaging

Not all processed fats are bad, study finds

Critical minerals on the agenda at IMARC 2025

Australians use more water than we think

Switchgear tech receives sustainable design award

NSW battery regulation moves from policy to action

Partnership to turn cooking oil into fuel

Magnetic flow meters: Verification and calibration within the process

US and Australian governments announce support for WA gallium project

Funding increased for local manufacturers to join US submarine supply chain

Viva Energy and Cleanaway partner to advance low-carbon fuels

From wartime wisdom to smart manufacturing: the power of condition monitoring